For the past 38 years, Tufts University School of Medicine and the Tufts Center for the Study of Drug Development (CSDD) have been hosting a Postgraduate Course in Clinical Pharmacology, Drug Development and Regulation.
The five-day program provides advanced instruction in practical and technical problem-solving in the areas of clinical pharmacology, drug development & clinical trial strategies, biopharmaceutical development, drug safety, and new drug regulation
This year’s course will take place from February 7 – 11, 2011.
This course is designed for individuals employed by pharmaceutical and biotechnology companies, regulatory agencies, academic institutions, outsourcing providers, consultancy firms, niche service providers, and other organizations involved in the research, development, regulation, and marketing of pharmaceutical products.
The activity’s goal is to provide a broad and basic overview of topics related to pharmaceutical development and regulation for professionals involved in pharmaceutical and biopharmaceutical innovation. The program will:
– Look at ways to integrate the relevant pharmacology, pharmacokinetics, and statistics related to drug development and the nature of evidence required for proof of efficacy and safety.
– Use a case-study approach to identify and solve practical, theoretical, and technical problems in human drug studies, and analyze an experimental design for a new drug candidate.
– Evaluate the science, laws, and regulations pertaining to the development and review of new drug products in the USA, Europe, Japan and other pharmaceutical markets.
TUSM designates this live activity for a maximum of 32.75 AMA PRA Category 1 Credits™. Physicians and pharmacists are eligible.
When and Where:
Dates: February 7-11, 2011
Where: Taj Boston Hotel (formerly the Ritz-Carlton), 15 Arlington Street, Boston, MA (website)
More information can be found on the CSSD website, including cost of registration and other details.
Jamison Guadalupe
Really enjoyed this article.Much thanks again. Want more.